Lipella Pharmaceuticals Inc. Common Stock (LIPO) Stock Forecast & Price Target
Lipella Pharmaceuticals Inc. Common Stock · NASDAQ
$0.00+0.00 (+0.00%)
15-min delayed · Aug 25, 8:00 AM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for LIPO yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $0.00 current
Highest Target—
Average Target—
Lowest Target—
LIPO EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts
Next period, 0 analysts expect Lipella Pharmaceuticals Inc. Common Stock to earn $0.00 a share (range $0.00 – $0.00), versus — a year earlier. , growing to $0.00 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —)., rising to $0 next year.
LIPO stock forecast FAQ
What is Lipella Pharmaceuticals Inc. Common Stock's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts, rising to $0.00 the following year.
How much revenue is Lipella Pharmaceuticals Inc. Common Stock expected to report next quarter?+
Consensus revenue is — (range — – —), growing to $0 next year.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LIPO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
